About Orbital Therapeutics
Orbital Therapeutics is a company based in Yellow Springs (United States) founded in 2022 was acquired by Bristol-Myers Squibb in October 2025.. Orbital Therapeutics has raised $270 million across 1 funding round from investors including ARE, Exor and Arch Venture Partners. Orbital Therapeutics offers products and services including RNA Medicines Platform and State-of-the-Art Technologies. Orbital Therapeutics operates in a competitive market with competitors including Cardinal Health, Harrow, FFF Enterprises, Threshold Enterprises and Senderra Rx, among others.
- Headquarter Yellow Springs, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$270 M (USD)
in 1 rounds
-
Latest Funding Round
$270 M (USD), Series A
Apr 26, 2023
-
Investors
ARE
& 13 more
-
Employee Count
Employee Count
-
Acquired by
Bristol-Myers Squibb
(Oct 10, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orbital Therapeutics
Orbital Therapeutics offers a comprehensive portfolio of products and services, including RNA Medicines Platform and State-of-the-Art Technologies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for designing RNA medicines tailored to specific diseases
Tools for calibrating RNA expression and tissue distribution in medicines
Unlock access to complete
Funding Insights of Orbital Therapeutics
Orbital Therapeutics has successfully raised a total of $270M through 1 strategic funding round. The most recent funding activity was a Series A round of $270 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $270.0M
-
First Round
First Round
(26 Apr 2023)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series A - Orbital Therapeutics | Valuation | Arch Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orbital Therapeutics
Orbital Therapeutics has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Exor and Arch Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Investment management services are offered by Newpath Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orbital Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orbital Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orbital Therapeutics Comparisons
Competitors of Orbital Therapeutics
Orbital Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Harrow, FFF Enterprises, Threshold Enterprises and Senderra Rx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple healthcare products and services are provided to organizations.
|
|
| domain | founded_year | HQ Location |
Ophthalmic products marketing services are provided by Harrow.
|
|
| domain | founded_year | HQ Location |
Distributes critical-care pharmaceuticals, vaccines, and specialty products to healthcare providers.
|
|
| domain | founded_year | HQ Location |
Distributors of fine natural and specialty products
|
|
| domain | founded_year | HQ Location |
Offers specialty medications, delivery, and support for patients with diseases like asthma and cancer.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orbital Therapeutics
Frequently Asked Questions about Orbital Therapeutics
When was Orbital Therapeutics founded?
Orbital Therapeutics was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Orbital Therapeutics located?
Orbital Therapeutics is headquartered in Yellow Springs, United States. It is registered at Yellow Springs, Ohio, United States.
Who is the current CEO of Orbital Therapeutics?
Ron Philip is the current CEO of Orbital Therapeutics.
Is Orbital Therapeutics a funded company?
Orbital Therapeutics is a funded company, having raised a total of $270M across 1 funding round to date. The company's 1st funding round was a Series A of $270M, raised on Apr 26, 2023.
What does Orbital Therapeutics do?
Orbital Therapeutics, backed by 270000000.0 from Arch Venture Partners, Andreessen Horowitz, Newpath Partners, ADG, Redmile Group, Exor, Invus, Moore Ventures, IGlobe Partners, Casdin Capital, Agent Capital, Alexandria, Heritage Medical Systems, focuses on providing healthcare solutions, pharmaceutical distributors, and specialty drugs. Distributor of RNA medicines. Driving innovation, growth, and excellence in its industry sectors.
Who are the top competitors of Orbital Therapeutics?
Orbital Therapeutics's top competitors include Cardinal Health, Harrow and Threshold Enterprises.
What products or services does Orbital Therapeutics offer?
Orbital Therapeutics offers RNA Medicines Platform and State-of-the-Art Technologies.
Who are Orbital Therapeutics's investors?
Orbital Therapeutics has 14 investors. Key investors include ARE, Exor, Arch Venture Partners, Bristol-Myers Squibb, and Andreessen Horowitz.